View ICR - OIRA Conclusion



0910-0776 201409-0910-002
Historical Active
HHS/FDA CDER
Guidance for Industry on Fees for Human Drug Compounding Outsourcing Facilities Under Sections 503B and 744K of the Federal Food, Drug, and Cosmetic Act
New collection (Request for a new OMB Control Number)   No
Regular
Approved without change 10/17/2014
09/08/2014
  Inventory as of this Action Requested Previously Approved
10/31/2017 36 Months From Approved
104 0 0
425 0 0
0 0 0